BURLINGTON, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2021 financial results on Thursday, July 29, 2021, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $54.50 per share. Gross proceeds to LeMaitre from the offering are expected to be approximately $54.5 million before deducting underwriting discounts and commissions and estimated offering expenses payable by LeMaitre. The offering is expected to close on or about July 16, 2021, subject to customary closing conditions. LeMaitre has granted the underwriters of the offering the right for a period of 30 days to purchase up to an additional 150,000 shares of common stock at the public offering price, less underwriting discounts and commissions.
No summary available.
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in the offering will be offered by LeMaitre. In addition, LeMaitre intends to grant to the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering, on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced preliminary unaudited results for the quarter ended June 30, 2021.
Did LeMaitre Vascular jeopardize its payout with its recent 16% dividend lift?
DUBLIN--(BUSINESS WIRE)--The "Vascular Patches Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com''s offering. Vascular patches are used for reconstruction of a damaged artery in the cardiovascular surgeries. It is usually placed at the site infection, which helps in reconstruction and maintenance of carotid arteries in postoperative wound infection. The vascular patches allows positive and safe angioplasty of an artery to be per
Up Market Research (UMR) announces the release of a new report, Clot Management Devices Market Research Report 2021. The statistics and insights provide an in-depth look into the market and opportunities. The report provides a comprehensive analysis of key market shares, size, trends, and forecasts for the global Clot Management Devices market. It also covers 
The global Vascular Patches market which projected a CAGR of approximately +7% in the midst of the estimate time span of 2020-2027. Coherent Market Insights has added a new report to its database that qualifies an expressive and professional look into
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Healthcare Conference on Thursday, June 10, 2021, at 5:30 PM ET.
Related Stocks: LMAT ,
Stratagem Market Insights, is a leading global market research firm, is pleased to announce its new report on Artificial Blood Vessel market, forecast for 2021-2028. The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that
Bioprosthetics Market Size, Status and Forecast 2021-2026 Global Bioprosthetics Market 2021-2026 in-depth study accumulated to supply latest insights concerning acute options. The report contains different predictions associated with Bioprosthetics market size, revenue, production, CAGR, consumption, profit margin, price, and different substantial factors. Whereas accentuation the key driving and Bioprosthetics restraining forces for this market, the 
No summary available.
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021, at 1:30 PM EDT.
- ← Vorige
- Weiter →